A Phase IV Clinical Trial to Evaluate the Preventive Effectiveness of NSAID-Associated Gastroduodenal Injury (Multi-center, Double-blind, Active-controlled, Stratified Randomized, Parallel Group)

Trial Profile

A Phase IV Clinical Trial to Evaluate the Preventive Effectiveness of NSAID-Associated Gastroduodenal Injury (Multi-center, Double-blind, Active-controlled, Stratified Randomized, Parallel Group)

Completed
Phase of Trial: Phase IV

Latest Information Update: 07 May 2017

At a glance

  • Drugs Eupatilin/jaceosidin (Primary) ; Aceclofenac; Misoprostol
  • Indications NSAID-induced gastrointestinal damage
  • Focus Therapeutic Use
  • Sponsors Dong-A ST
  • Most Recent Events

    • 29 Sep 2014 Status changed from recruiting to completed as reported by ClinicalTrials.gov record.
    • 06 Aug 2013 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top